A Later Null Comparison Was Not the Same as a Significant Recovery Interaction

The statistical evidence for recovery differed across outcomes in an alcohol–cannabinoid mouse study. A later nonsignificant group comparison did not establish the same treatment-by-time interaction for every response.

The study assessed two recovery intervals

Pava and colleagues compared cannabinoid responses one and ten days after repeated ethanol. Earlier differences were no longer significant in the later comparisons, supporting the authors’ account of reversibility within the observation window.

The interaction tests supplied an additional distinction

The treatment-by-day interaction was significant for locomotor activity and body temperature. It was not significant for antinociception, where the reported interaction p value was 0.1141, despite a significant overall treatment effect and a null later pairwise comparison. Those are different statistical questions.

Recovery claims should retain both analyses

A null comparison at the later visit does not establish exact equivalence or determine when the groups converged between visits. A nonsignificant interaction likewise does not prove that no recovery occurred. The defensible account describes the observed endpoint comparisons and the strength of evidence for differential change over time separately. It does not convert a ten-day animal observation into a guaranteed cannabis-tolerance reset schedule for people or a claim that every measured function recovered identically.

Related analysis: The tested agonist and direction of alcohol–cannabinoid cross-tolerance.

Research cited

Pava MJ, Blake EM, Green ST, Mizroch BJ, Mulholland PJ, Woodward JJ. Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol. Psychopharmacology (2012).

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Different Amygdala Findings Varied by Both Subregion and Recording Method

Apparently different cannabinoid effects within the central amygdala could not be assigned solely to anatomy when recording methods differed as well. A paper discussing its medial recordings identified this interpretive limit. The current experiment measured spontaneous transmission Varodayan and colleagues recorded spontaneous and miniature GABAergic currents from the medial subdivision…

Spread the love

Read Article: Different Amygdala Findings Varied by Both Subregion and Recording Method

CB1 and CB2 Antagonists Gave Different Answers for WIN’s Synaptic Effect

A drug capable of activating more than one cannabinoid receptor needs evidence identifying the receptor responsible for a particular effect. A rat amygdala experiment compared CB1 and CB2 antagonism rather than relying only on WIN55,212-2’s drug-class label. The agonist first reduced inhibitory-current frequency Varodayan and colleagues applied WIN to central-amygdala…

Spread the love

Read Article: CB1 and CB2 Antagonists Gave Different Answers for WIN’s Synaptic Effect

A Weaker Direct WIN Response Did Not Eliminate Its Interaction With Alcohol

After chronic alcohol exposure, an experimental cannabinoid agonist had a diminished direct effect on GABA release but still prevented an acute alcohol-related increase. Reduced sensitivity depended on which response was being examined. The direct agonist challenge was attenuated Varodayan and colleagues found that WIN55,212-2 reduced inhibitory-current frequency in alcohol-naive rat…

Spread the love

Read Article: A Weaker Direct WIN Response Did Not Eliminate Its Interaction With Alcohol

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us